Your browser doesn't support javascript.
loading
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet, Nancy; Fernández-Ruiz, Mario; Binet, Isabelle; Dickenmann, Michael; Dahdal, Suzan; Hadaya, Karine; Müller, Thomas; Schaub, Stefan; Koller, Michael; Rotman, Samuel; Moll, Solange; Hopfer, Helmut; Venetz, Jean-Pierre; Aubert, Vincent; Bühler, Léo; Steiger, Jurg; Manuel, Oriol; Pascual, Manuel; Golshayan, Dela.
Afiliación
  • Perrottet N; Service of Pharmacy, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Fernández-Ruiz M; Transplantation Center, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Binet I; Nephrology and Transplantation Medicine, Cantonal Hospital St. Gallen, St Gallen, Switzerland.
  • Dickenmann M; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Dahdal S; Division of Nephrology, Hypertension and Clinical Pharmacology, Inselspital Bern, Bern, Switzerland.
  • Hadaya K; Division of Nephrology and Division of Transplantation, Geneva University Hospitals, Geneva, Switzerland.
  • Müller T; Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.
  • Schaub S; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Koller M; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Rotman S; Service of Clinical Pathology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Moll S; Division of Clinical Pathology, Department of Pathology and Immunology, Geneva University Hospitals, Geneva, Switzerland.
  • Hopfer H; Pathology Institute, University Hospital Basel, Basel, Switzerland.
  • Venetz JP; Transplantation Center, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Aubert V; Service of Immunology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Bühler L; Visceral and Transplant Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
  • Steiger J; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Manuel O; Transplantation Center, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Pascual M; Service of Infectious Diseases, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Golshayan D; Transplantation Center, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
PLoS One ; 16(4): e0250829, 2021.
Article en En | MEDLINE | ID: mdl-33930037

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Plasmaféresis / Rituximab / Rechazo de Injerto / Supervivencia de Injerto / Infecciones / Suero Antilinfocítico Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Plasmaféresis / Rituximab / Rechazo de Injerto / Supervivencia de Injerto / Infecciones / Suero Antilinfocítico Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos